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Upgrading mouse health and welfare: direct
benefits of a large-scale rederivation
programme
M D Fray*, A R Pickard*, M Harrison† and M T Cheeseman‡
*Mammalian Genetics Unit, Medical Research Council, Harwell, Oxfordshire, UK; †Quarantine Group,
Mary Lyon Centre, Medical Research Council, Harwell, Oxfordshire, UK; ‡Pathology Group, Mary Lyon
Centre, Medical Research Council, Harwell, Oxfordshire OX11 0RD, UK
Summary
We report the outcome of a 30-month programme to rederive 310 specific pathogen-free mouse
strains to populate a new individually ventilated cage barrier facility at the Mary Lyon Centre
(MLC), Medical Research Council (MRC) Harwell. Themicewere rederived in a self-contained
quarantine suite and embryo-recipient females were health-screened to assess microbiological
status, before moving their offspring into the new facility. The MLC currently houses
approximately 49,000 mice in about 9750 cages and we have 30 months of follow-up health
screen data. Embryo rederivation and hysterectomy have high safety margins; however, the
precaution of performing the programme in isolators facilitated the containment and
decontamination of twomouse hepatitis virus (MHV) infection outbreaks. Rederivation of the
colony has eliminated endemic MHV, mouse adenovirus type 2 (MAV-2), Theiler’s murine
encephalomyelitis virus, pinworms, intestinal protozoa, Pasteurella pneumotropica,
Helicobacter spp. and mites. The improvements in microbiological status have had notable
benefits for mouse health and welfare and the science at MRC Harwell. Previously important
clinical entities such as sudden death associated with lactation ileus in C3H/HeHmice, early
weight loss associated with inflammatory bowel disease in B6-TgN(HDexon1)61Gpb and B6-
TgN(HD82Gln)81Dbo (Huntington) mice and early weight loss in male mice mutagenized
with N-ethyl-N-nitrosourea have been markedly reduced or eliminated.
Keywords Embryo transfer; in vitro fertilization (IVF); specific pathogen free (SPF); health;
welfare
Upgrading mouse house facilities presents a
unique opportunity to improve the micro-
biological status of stocks and thereby
improve the health and welfare of mice. In
addition to the effort to upgrade mouse
facilities, Europe’s scientific community is
making a concerted effort to standardize the
health-screening programmes (e.g. Federation
of European Laboratory Animal Science
Associations [FELASA] recommendations;
Nicklas et al. 2002) to achieve better stan-
dards of health and thereby improve the
characterization of mouse models of mam-
malian physiology and human disease. There
is also recognition of the need to generate
reproducible results for a series of standar-
dized mouse models in multicentre studies,
e.g. EUMORPHIA, EUROHEAR, EUMODIC
and other integrated research programmes.
This paper discusses the strategy, costs and
benefits of a large-scale, 30-month programme
to rederive 310 mouse strains into the Mary
Lyon Centre (MLC), a new individually
ventilated cage (IVC) barrier facility with a
maximum cage capacity of 13,000. This
specific pathogen-free (SPF) facility currently
houses approximately 49,000 mice in about
9750cages andthetwopre-existing ‘lowhealth’
Correspondence: M T Cheeseman.
Email: m.cheeseman@har.mrc.ac.uk
Accepted 24 May 2007
# Laboratory Animals Ltd DOI: 10.1258/la.2007.007005. Laboratory Animals (2008) 42, 127–139 by guest on February 13, 2014lan.sagepub.comDownloaded from 
status mouse houses, which had to operate in
parallel for 26 months, are now closed.
During this exercise, the key decisions were
to conduct the rederivations in an adjacent but
separate self-contained quarantine suite in
which mice were housed in isolators and to
institute a suitable sampling and microbiolo-
gical testing programme for isolators to control
the quality of the mice. To date, 30 months of
follow-up sentinel screening in the MLC
indicates that we have achieved our goal of
eradicating the endemic infectious agents in
our pre-existing, largely conventional colo-
nies. The impact of this rederivation exercise
on health and welfare was assessed by
comparing the occurrence of specific disease
entities in pre-existing conventional colonies
with the SPF colonies within the MLC.
Other units upgrading their animal facili-
ties will develop their own programme to
improve health status depending on their
specific infection problems, access to rederi-
vation technology, caging, colony size,
budgets, staffing and building design. This
paper aims to highlight some of the broader
issues such as the limits of rederivation to
sanitize stocks as well as the constraints on
health screening in isolators to monitor
microbiological status and the acquisition of
adequate data to assess the impact on clinical
health and welfare.
Materials and methods
Animals
The humane care and use of mice in the
rederivation programme was conducted
under the Home Office (HO) project licence
PPL 30/1704, the N-ethyl-N-nitrosourea
(ENU) mutagenesis programme under PPL
30/2049 and the breeding of inbred mouse
stocks in the MLC under the HO Certificate
of Designation 30/4303.
Rederivation of mice
The rederivation of mice began in March
2004 and was conducted by the frozen
embryo and sperm archive (FESA) core. The
protocols used in this study for embryo
freezing/thawing, embryo handling, in vitro
fertilization (IVF) and superovulation
techniques are described on the European
Mouse Mutant Archive (EMMA) website:
www.emmanet.org. Embryo collection,
culture and unilateral and/or bilateral trans-
fer of preimplantation embryos into pseudo-
pregnant recipient females were performed
using the general protocols described by
Nagy et al. (2003). However, all surgery was
performed under general gaseous anaesthe-
sia. Anaesthesia was induced with 4%
isoflurane (Abbott Laboratories, Queens-
borough, UK) then maintained with 1.5%
isoflurane throughout the procedure. After
surgery, 1 mg/kgbodyweightof buprenorphine
(Vetergesic: Reckitt Benckiser Healthcare,
Hull, UK) in 0.1 mL of sterile saline was
administered as a subcutaneous injection for
postoperative analgesia. The micewere then
placed in a warm recovery area before transfer
to the appropriate isolator. All mice were
observed daily.
All preimplantation embryos were
transferred into pseudo-pregnant SPF
Crl:CD-1(ICR) female recipients, sub-
sequently referred to as CD-1 females. In the
first instance, the CD-1 females were pur-
chased from Charles River, UK and delivered
to Harwell on the day of plug. Once CD-1
production was established inside the MLC,
the pseudo-pregnant females were generated
in-house. Each pseudo-pregnant female was
free of the following FELASA listed agents
(Nicklas et al. 2002): ectromelia, lymphocy-
tic choriomeningitis virus, minute virus of
mice (MVM), mouse adenovirus type 1 (FL)
(MAV-1), mouse adenovirus type 2 (K87)
(MAV-2), mouse cytomegalovirus, mouse
coronavirus (mouse hepatitis virus, MHV),
mouse parvovirus (MPV), mouse rotavirus
(EDIM), pneumonia virus of mice, reovirus 3,
Sendai virus, Theiler’s murine encephalo-
myelitis virus (TMEV), Citrobacter roden-
tium, Clostridium piliforme,
Corynebacterium kutscheri, Helicobacter
spp., Mycoplasma spp., Pasteurella spp.,
salmonella spp., Streptobacillus monilifor-
mis, streptococci b-haemolytic (not group
D), Streptococcus pneumoniae, endopara-
sites and ectoparasites. The CD-1 embryo
recipients were positive for intestinal proto-
zoan Entamoeba muris, but these are con-
sidered non-pathogenic commensals.
128 M D Fray et al.
Laboratory Animals (2008) 42  by guest on February 13, 2014lan.sagepub.comDownloaded from 
Supplemental bacteriological screening
data provided by Harlan UK (Harlan UK Ltd
Technical Services Department,
Loughborough, UK, see below) from routine
aerobic culture of the nasopharynx and
intestine indicated that the CD-1 mice used
in the rederivation programme carried the
non-FELASA listed bacteria Staphylococcus
aureus, Staphylococcus spp., a-haemolytic
streptococci, Streptococcus spp., Proteus
spp., Lactobacillus spp., Enterobacter spp.
and Escherichia coli.
Husbandry
(1) The two pre-existing mouse houses
(designated building 371 and building
383, respectively) were operated for an
overlapping period of 26 months with
the MLC but were finally closed in May
2006. Over 95% of the mouse stocks in
these two mouse houses were conven-
tionally housed in open topped cages,
the remainder of the mice were housed
in IVCs (Charles River, UK). The
environmental conditions were 12 h
light/dark (07:00–19:00 light phase)
cycle, 19–238C and 45–65% relative
humidity. Mice were housed on grade 6
sawdust bedding (Datesand, Manchester,
UK). All cages, cage tops, bedding, water
bottles and caps were sterilized by auto-
claving before use. Water bottles and
cages were changed once a week.
Husbandry for IVC stocks was per-
formed in a class II biological safety
cabinet and these were surface-sterilized
with 70% alcohol between different
colonies, then wiped down with 2%
Trigene spray (Sychem, Chandler’s Ford,
Hampshire, UK) at the end of the
session. Mice were fed RM3 breeding
diet (Special Diets Services, Witham,
UK) and provided with chlorinated
(9–13 ppm) tap water ad libitum. All
mice were checked daily.
(2) The MLC’s quarantine suite is a separate
self-contained barrier facility adjacent to
the main centre with its own high-
efficiency particulate air (HEPA)-filtered
system and cage wash facilities. The
quarantinesuite itself comprises changing
rooms, three animal rooms, a stores area,
office, staff room, vaporized hydrogen
peroxide (VHP) lobby, small general
purpose laboratory, a laminar air flow
(LAF) cabin connecting theVHP lobbyand
the small general purpose laboratory and a
clean rederivation laboratory. All con-
sumables were brought into the barrier
after external sterilization with VHP.
Staff members entering the quarantine
suite take a wet-shower before changing
into unit clothing and mob cap, before
leaving the changing rooms. They then
put on over-suits before entering the
interior of the facility. All staff leaving the
quarantine suite remove their over-suits
before entering the changing rooms and
then remove their unit clothing before
crossing the step over barrier and putting
on their outside clothing.
Clean CD-1 recipient females entered
the quarantine suite in their home cages
through the VHP lobby. The home cages
were placed on the LAF cabins platform
and themice transferred toa sterile IVCon
the ‘clean’ side of the LAF cabin. The IVC
was then taken to the rederivation labora-
tory where the embryos were implanted
under general anaesthesia on the open
bench. After surgery, the mice were
allowed to recover inside a sterile IVC
before being transferred to the appropriate
isolator.
When low-health status mice entered
the facility, the home cage was triple-
bagged inside the LAF cabin before it was
taken straight to the designated isolator.
The quarantine suite supported 20
flexible film isolators (Harlan Isotec,
Bicester, UK), 10 of which could
accommodate 50 mouse cages. The
remaining isolators held 20 mouse cages.
Each isolator had its own filtered water
supply and stores port. The outer
packaging of all supplies entering/
leaving the stores port was saturated
with 2% Trigene spray for 60 min. The
stores port was also used to facilitate the
movement of live mice into and out of
the isolators. Before entering/leaving the
isolator, live mice were placed inside
a sterile IVC in the stores port which
Health status and welfare in rederived mice 129
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was then saturated with 2% Trigene
spray for 10 min. All movements into
and out of the isolators were logged on
daily record sheets.
Before use, each isolator was fumi-
gated with VHP and tested for sterility
before any mice were introduced. An
isolator was considered sterile if no bac-
terial growth was detected in swabs
taken from 10 separate locations and
cultured in Luria-Bertani (LB) broth
(Gibco, Paisley, UK) for three days at
378C. Isolators containing ‘clean’ reder-
ived mice were maintained under posi-
tive pressure (50–100 Pa of water).
However, those isolators that housed
mice with a low-health status were
maintained under negative pressure (50–
100 Pa of water). Both positive and
negative pressure isolators were run in
parallel from June 2005 onwards.
The environmental conditions in the
quarantine suite were: 12 h light/dark
(07:00–19:00 light phase) cycle, 19–
238C and 45–65% relative humidity. All
consumable items used in the isolators
were bagged and autoclaved or irradiated
before use. The mice were supplied with
chlorinated (9–13 ppm) reverse osmosis
water and the contents of the drinking
bottles were completely changed once a
week after which tests showed chlorine
levels .5 ppm. Irradiated RM3 breeding
diet was supplied by Special Diets
Services, Witham, UK. Food and water
was provided ad libitum. All husbandry
procedures were performed within the
isolators and cage bedding was changed
weekly. During cage changing, mice
were placed in a holding container and
the soiled bedding from their cage was
scraped out and replaced after a sanitary
wipe of the interior bottom of the cage
with 2% Trigene. Technicians did not
wipe their gloves or disinfect the scraper
between cages to promote environ-
mental mixing and cross-contamination
with any potential infectious material.
Records kept for each rederivation
included pregnancy rates, number and
gender of pups born, number of pups
found dead (removed at daily cage
checks), those missing at weaning and
those weaned.
(3) The MLC itself is a mouse-only facility,
which has been open since June 2004. It
has its own HEPA-filtered air system and
mice are housed in IVCs (Techniplast
UK Ltd). Cages are changed weekly in
class II biological safety cabinets, other-
wise the food, water and environment
are as described for the quarantine suite.
On entering, the MLC staff replace their
outside clothing with unit clothing, mob
cap and over-suit. The staff then pass
through an air-shower before entering
the main facility. The production ward
and wards 2–6 are managed as separate
barriers (production staff wet-shower in
and change their over-suits before
entering the ward).
Sentinel screening
Depending on their availability, C57BL/6J,
CBA/CaH, BALB/cAnNCrl, FVB/NCrlBr or
CD-1 mice reared in IVCs were used as
sentinels.
(1) The pre-existing conventional mouse
rooms contained 200–300 cages and one
sentinel cage was set up in each room
containing four male or female weanling
mice; pathogen challenge was by air-
borne exposure. One sentinel mouse
(each exposed for 5–21 weeks) was sent
for microbiological testing (see below)
from each cage at three-month intervals
and tested according to FELASA guide-
lines (Nicklas et al. 2002). For IVC
monitoring, sentinel cages were chal-
lenged with a 12.5 mL scoop of dirty
bedding collected from each of eight
cages every week. This screens the
56-cage rack in a seven-week rotation.
(2) Screening the isolators in the quarantine
suite comprised two separate groups of
CD-1 embryo recipient dams randomly
sampled from different boxes and
screened before transferring their off-
spring into the barrier facility. The first
four dams were screened when their
pups were weaned, and the second four
130 M D Fray et al.
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were screened three weeks later (6 and 9
weeks post-embryo transfer, respect-
ively) for the full annual FELASA panel.
The rationale for having a six and a nine-
week screen was to identify and eradi-
cate any infection outbreaks as soon as
possible to minimize the possibility of
accidental cross-infection between iso-
lators. After two clear rounds of health
screening, offspring were transferred to
the MLC in sterile IVCs.
(3) The health-screening programme for
IVCs in the MLC used either CBA/CaH
or CD-1 mice as sentinels and these
were challenged by transfer of dirty
bedding with one sentinel cage set up
per 56 IVC cages, i.e. one side of a cage
rack as previously described (Cheeseman
et al. 2007).
Microbiological testing
Live mice were submitted to an outside
laboratory (Harlan, UK) for microbiological
testing based on FELASA recommendations
(Nicklas et al. 2002). The full ‘annual’ panel
was performed twice on mice from the
isolators in the quarantine suite. Screening
followed the quarterly FELASA programme
in the mouse wards within the MLC, the
exception being the production ward where
inbred strains were screened monthly. The
efficient flow of rederivation work through
the quarantine facility depended on the
timely delivery of microbiological test
results. We therefore obtained a service level
agreement with Harlan for our results to be
provided within seven working days and any
positive test results within 1–2 days.
Pathology screening
A total of 1670 mouse necropsies were
performed between March 2003 and January
2007. This period spans the rederivation pro-
gramme and the establishment of SPF colo-
nies in the new SPF facility. The animal care
technicians selected cases for examination on
the basis of health concerns, whereas pheno-
typing necropsies were performed for scienti-
fic purposes to characterize mouse mutant
phenotypes. The number of mice submitted
from each stock, their age, gender, the under-
lying size of the colonies and the ages of the
mice at the endpoint of experiments varied
considerably. This confounds analysis of the
effect of rederivation on disease incidence. To
simplify the comparison, we analysed the
husbandry and pathology records for a few
well-defined clinical disease entities in
particular mouse stocks. These disease enti-
ties were lactation ileus in C3H/HeH female
mice, inflammatory bowel disease (IBD) in
transgenic Huntington mice and weight loss
in ENU-treated male BALB/cAnNCrl mice.
Previously published data were also available
for the otitis media (OM) mutant
C3H.C-EviJbo/H, subsequently referred to as
Junbo, in conventional and SPF conditions
(Parkinson et al. 2006). In addition, we exam-
ined the MLC pathology records for the fol-
lowing conditions: abscesses, pyelonephritis
and botryomycosis. Mice for necropsy were
humanely euthanized by an overdose of
barbiturate administered intraperitoneally
(Pentoject, Animalcare, York, Yorkshire, UK)
and blood for serum was collected by cardiac
puncture.Micewereweighed then necropsied
and selected organs examined by histology as
previously described (Cheeseman et al. 2007).
Importation of ‘dirty’ stocks into quarantine
The rederivation team also import low-
health status mice for cryopreservation as
part of their remit as a member of EMMA
(www.emmanet.org). To improve infection
control, mice from colonies with documen-
ted health problems were received into a
separate isolation facility outside the quar-
antine suite. Where possible, only dissected
male or female reproductive tracts were
taken into the quarantine suite prior to
harvesting embryos or germplasm. However,
when it was essential to expand ‘dirty’ stocks
this was done in the quarantine suite in
designated negative pressure isolators.
Embryo recipients from these rederivations
were housed in a second isolator. If
pinworms were endemic in the originating
colony, we routinely requested that the mice
were treated before shipping. During their
stay in quarantine, mice were treated by
topical application of ivermectin once a week
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for the first three weeks, then once per
month for the next three months. Mice were
transferred to a clean cage for treatment and
their coats were lightly sprayed with a 10%
solution of Panomec (Merial Animal Health,
Harlow, Essex, UK) with the intention that
the drug was ingested during grooming.
The bedding in the home cage was also
misted at the same intervals. The treatment
was directed by the named veterinary
surgeon. In addition to routine CD-1 sentinel
screening, postmortem serum samples from
imported stocks were tested for MPV, MVM
and Mycoplasma spp. Currently, sentinels
from quarantine isolators containing
imported live mice were sampled at six and
nine weeks in-line with the rederivation
isolators to gather additional information on
the rates of transmission of infectious agents
within isolators.
Results
Microbiological status of mice before
rederivation
Results for a sentinel screen operated from
September 2002 to May 2005 are presented in
Table 1. In addition to these agents, patho-
logy screens identified single cases of
Mycoplasma pulmonis lung infection
(confirmed by follow-up serology) and
Pneumocystis carinii in 2003. Cases of C.
piliforme (Tyzzer’s disease) were identified in
1993. Microbiology screens in IVCs, in the
pre-existing mouse houses detected
pinworms in building 383 IVCs and MHV,
were occasionally detected in sentinels and
in experimental animals housed in building
371 IVCs (data not shown).
Many of the oocytes, spermatozoa and
embryos used for the rederivation exercise
were collected from mice from the infected
MRC Harwell colonies. This was illustrated
in some inbred strains that were bred and
weaned in IVCs and were then moved into
conventional cages prior to superovulation
and oocyte harvesting. In one such example,
a group of 19 clinically well, but immuno-
logically naı¨ve, C3H/HeH females, were
examined by postmortem histology after
oocyte collection and 68% had mucosal
MHV syncitial cells in their intestines. MHV
syncitia were also found at postmortem in
20% of conventionally-reared, superovulated
C57BL/6J females (n ¼ 10).
Rederivation
To date, a total of 28,667 embryos have been
transferred into 1872 recipient females as
part of the ongoing rederivation exercise and
an overall littering rate of 27.8% has been
achieved. A total of 14,144 of these embryos
were generated using IVF and they were
transferred into 849 recipient females (28.2%
littering rate). The remaining 14,523
embryos were derived in vivo from
super-ovulated mice and were transferred
into 1023 recipient females (26.9%
littering rate).
These embryos have been used to resurrect
306 stocks, 127 of which were resurrected
using IVF-derived embryos. Hysterectomy
rederivation was used to rederive four stocks
into the MLC. Live mice from three SPF
stocks from commercial suppliers were
imported into the MLC without prior reder-
ivation, but only after they had been housed
in an isolator and two batches of sentinel
mice had been sent off for screening at six
and nine weeks post-arrival.
Microbiological screens on rederived and
imported mice in quarantine
In 95 isolator cycles, there were two MHV
outbreaks that were eradicated by culling all
mice and re-sterilization of the affected
isolator (Table 1). The first outbreak occurred
in an isolator used to rederive six embryo
stocks. In this case, 4/4 dams out of 39 reci-
pient females and their 91 pups were positive
for MHV antibodies six weeks after embryo
transfer (at the time their pups were weaned).
Immediate follow-up serology tests
confirmed an additional group of five dams
from the same isolator were all MHV-
positive. At first, suspicion fell on frozen/
thawed IVF-derived embryos used to recover
two of the six embryo stocks, the other four
stocks being derived from frozen/thawed in
vivo derived embryos. The second MHV
outbreak (4/4 positive dams at the 6-week
screen) occurred in an isolator used to
132 M D Fray et al.
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rederive three of these frozen embryo stocks
in 15 recipient females. One of these frozen
embryo stocks was common to the first
MHV outbreak. We suspected, but could not
be certain, that MHV infection was trans-
mitted from these frozen thawed in vivo
derived embryos, perhaps because of adher-
ent infected material (Peters et al. 2006).
New batches of embryos were therefore gen-
erated for these two stocks and the lines were
subsequently rederived free of infectious
agents. There was no wave of overt clinical
sickness in either MHV outbreak or pre-
weaning mortality. We have also seen trans-
mission of Helicobacter spp. (to 100% of
sentinels by 6 weeks) from ‘dirty’ mice to
isolator sentinels.
Clinical health and welfare in rederived
SPF mice
(1) Lactation ileus in C3H/HeH female
mice
Lactation ileus (Kunsty´rˇ 1986) was a
major problem in conventional C3H/
HeH mouse colonies because sufficient
numbers of foster mothers could not be
found for orphaned pups. Typically, there
was a peak of sudden-onset deaths or
morbidity at 6–15 days postpartum in
females in their first lactation cycle (data
not shown) with no premonitory signs of
illness. Postmortem examination find-
ings were distended intestines with
minimal histological pathology and no
evidence of a specific viral or bacterial
pathogen. In conventional mouse colo-
nies, the morbidity/mortality rates were
115 out of 936 breeding females in one
six-month period in 2003–2004. In
30 months operation of the MLC, there
have been no cases of lactation ileus in
C3H/HeH breeding females. There are
currently approximately 300 C3H/HeH
females in mating and they have
2–5 litters each. There has been no
evidence of postpartum morbidity or
mortality associated with the first or
second pregnancies.
(2) Inflammatory bowel disease in
transgenic Huntington mice
In 28 months, 94 transgenic Huntington
mice aged between 4 and 20 weeks were
culled because of welfare concerns and
weight loss and 79% had histological
evidence of ulcerative colitis/typhloco-
litis, but had no evidence of a specific
viral or bacterial pathogen. In the MLC,
there have been 18 necropsies performed
on Huntington mice. Of these, seven
had no clinical signs of illness and the
necropsies were performed for scientific
interest. One mouse aged 25 weeks had
rectal haemorrhage associated with
typhlocolitis; and in two further mice
aged 49 weeks without clinical signs,
one had histological enteropathy and the
other had low-grade typhlocolitis.
(3) Weight loss in ENU-treated male
BALB/cAnNCrl mice
SPF BALB/cAnNCrl males were used in
the ENU mutagenesis programme in the
pre-existing mouse facility. Although
they were housed in IVCs, the barrier
sometimes failed and in one batch of 50
mice treated with three 90 mg/kg doses
of ENU, half were culled for acute post-
treatment and 20% weight loss. Selected
males were examined at postmortem
and had intercurrent enteropathic MHV
infection. Analysis of the health records
of the first 24 batches of ENU muta-
genized BALB/cAnNCrl and C57BL/6J
males (n ¼ 401) in the MLC indicated
that only a single mouse was culled with
weight loss in the immediate post-
treatment period. This mouse was not
examined at necropsy or by histology,
but based on the sentinel screening in
the MLC FELASA agents were not
contributory.
(4) Pyogenic infections in SPF mice
There were 40 cases of pyelonephritis, 14
cases of abscesses (in preputial gland,
lung, lymph node and skin) and seven
cases of staphylococcal botryomycosis
over 30 months in the SPF mouse colo-
nies in the MLC. These tended to be
single cases of infection in both males
and females in a range of inbred and
genetically altered strains of mice.
This sporadic pattern of cases in
SPF mice was similar to the
pattern in conventional mice (data not
shown).
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Costs of rederivation
This large-scale rederivation programme for
the conventional mouse colonies was built
on the expertise of a seven-member FESA
team that was already well established in the
Mammalian Genetics Unit (MGU) at MRC
Harwell. The cryopreservation of MGU
stocks was conducted in earnest over a
2.75-year period and represents 5.5 person-
years of work. The rederivation programme
conducted in MLC quarantine was approxi-
mately 3.75 person-years work. The purchase
and delivery of pseudo-pregnant CD-1
females cost £25K and additional screening
of mice in quarantine cost were £81K along-
side the £75K screening costs for the MLC
mouse colonies over the same period. To put
this in perspective, the construction and
equipment costs for the MLC were £18M
with an annual recurrent budget (including
staff salaries, consumables, power and utili-
ties) of £5M and a combined FESA and MLC
staff of 91.
Discussion
We are cautiously optimistic that the rederi-
vation programme has eliminated previously
endemic FELASA listed agents MHV, MAV-2,
TMEV, intestinal protozoa, pinworms, ecto-
parasites, Pasteurella pneumotropica and
Helicobacter spp. The key decision for our
success was to perform the programme in a
separate quarantine facility equipped with
isolators so that infection outbreaks could be
contained and decontaminated safely.
The rederivation exercise required the
recovery of a variety of genetically altered
and inbred strains reflecting the ongoing
scientific effort at the MRC Harwell. To
facilitate the cryopreservation of many of
these strains, we archived two-cell embryos
generated by IVF. Our average littering rate of
28%, using embryos harvested predomi-
nantly from genetically altered strains, is
comparable with published data on the
recovery of live pups from frozen/thawed
two-cell embryos from inbred mouse strains
(Byers et al. 2007).
Rederivation of mice, whether by transfer-
ring in vivo-derived or IVF-derived embryos
or by cross-fostering hysterectomy-derived
pups, appears to be intrinsically very safe
(Reetz et al. 1988, Suzuki et al. 1996),
although it has not been conclusively
demonstrated to remove all pathogenic
agents that infect mice, e.g. Mycoplasma
spp. (Hill & Stalley 1991, Homberger &
Thomann 1994). Nevertheless, the low risks
of disease transmission during the rederiva-
tion of mice are multiplied when large
number of procedures are performed.
Our isolator screening programme met the
FELASA recommendations to screen 3–5
sentinels at increased frequency (i.e. in less
than 3-month intervals) (Nicklas et al. 2002).
The confidence limits for detecting infec-
tions using different sample sizes can be
determined mathematically based on
random sampling of the dams and assumed
rates of infection for different agents using
the following formula: n ¼ log (1 2 prob-
ability of detecting infection)/log (1 2
assumed infection rates) adapted from
Lindsey et al. (1991). In our screens (a total of
n ¼ 8 by 9 weeks), there was a 99% prob-
ability of detecting a 44% infection rate in at
least one animal and a 95% probability of
detecting a 31% infection rate. In practice,
there is a limit to detecting low rates of
infection because the number of mice
required for screening is inversely pro-
portional to the percentage of uninfected
mice (Nicklas et al. 2002). For example,
doubling sampling size (and cost) to n ¼ 16
would detect an assumed infection rate of
17%, P ¼ 95% (c.f. n ¼ 8 used in this pro-
gramme to detect 31% infection rate, P ¼
95%), and sampling aimed at detecting even
lower rates of infection would become
impractical and prohibitively expensive. A
practical approach was to promote infection
transmission within isolators to an easily
detectable infection level, ideally 40%.
Empirical data from this study indicated that
this occurred for some agents. MHV infec-
tion was observed to spread rapidly (6
weeks) and the 100% infection rate was sig-
nificantly higher than in sentinels in con-
ventional rooms (13/13 positive cases versus
238/328, P, 0.02 Fisher’s exact test).
Additional information on the spread of
infections within isolators came from
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housing ‘dirty’ imported mice. Helicobacter
spp. transmitted to 100% of sentinels within
six weeks. The lack of transmission of pin-
worms to sentinels may have been due to
effective ivermectin prophylaxis. However,
we did not test every individual imported
mouse from infected colonies and these mice
may not have carried infections. The latter
may explain why we have not seen
P. pneumotropica-positive sentinels after
they were housed with mice from
P. pneumotropica-positive colonies. It is also
conceivable that we could import ‘dirty’
mice that have seroconverted to infectious
agents, but do not have active infection and
are not infectious to other mice. While rela-
tively low sentinel seroconversion rates for
some agents in large conventional rooms
(,10% for MAV-2 and TMEV, Table 1) might
not equate to low transmission rates in iso-
lators, we attempted to mitigate the effects of
slow infection transmission/post-infection
seroconversion by including a nine-week
screen. As yet, no additional agents have
been identified in the latter screen.
Extending the isolator screening period
beyond nine weeks would have slowed the
overall programme and prolonged the risk of
having infected mice on site, while the
‘dirty’ mouse houses were run alongside the
new facility. Furthermore, rederived mice
have to be young enough to breed well and
space constraints did not allow breeding in
quarantine.
We based our decisions on whether or not
to import low health status live mice after
reviewing health-screening health data
supplied from the submitting institution. We
regarded importation of live ‘dirty’ stocks
into quarantine as potential cross-infection
risk while the rederivation programme was
underway. To reduce this risk, we ran isola-
tors with ‘dirty’ mice at negative pressures
and those with rederived mice at positive
pressures. Special containment has to be
considered for live mouse imports if there is
a risk they carry agents such as MPV which
are shed for an extended period, long-lived in
the environment and to which mice sero-
convert relatively slowly. Our policy would
be to collect sperm or embryos outside the
quarantine barrier and avoid long-term
holding in quarantine isolators. We also
adopted retrospective testing of imported
stock for some troublesome infections such
as MPV, MVM and Mycoplasma spp. as
another precaution to assess ongoing risks.
None of these agents has been detected to
date.
Unfortunately, it was not straightforward
to compare clinical health and welfare of the
pre-existing conventional mouse colonies
with the SPF mice inside the MLC.
Potentially useful indicators such as pre-
weaning mortalities were difficult to
compare because breeding programmes were
altered and we imported new founder stock,
e.g. DBA/2J, BALB/cAnNCrl and CD-1 from
UK suppliers in order to build breeding
stocks up quickly. The analysis of the effect
of rederivation on disease incidence mice
based on our diagnostic and phenotyping
pathology records was hampered by uneven
sampling between conventional and SPF
colonies. Case submission was determined
by recognition of mouse ill health (i.e.
without matching genetic backgrounds, age,
gender, colony size, etc.) or for research
interest. However, some inferences can be
drawn using selected examples of well-
defined disease entities in specific stocks.
Before this discussion, it is important to note
the limits of our rederivation programme.
The CD-1 stocks purchased for use in the
rederivation programme, and thereby all
stocks rederived into the MLC, were not
germfree and carried a number of bacterial
agents. Although these were not FELASA
listed agents, some such as S. aureus and
a-haemolytic streptococci can be a cause of
clinical disease in immunocompetent mice
as well as immunodeficient mice (Nicklas
et al. 2002). It was beyond the scope of our
rederivation programme to remove these
non-FELASA listed bacteria from our
colonies S. aureus and a-haemolytic strep-
tococci may have been the cause of the pyo-
genic infections we have seen such as the 40
cases of pyelonephritis, 14 cases of abscesses
(in preputial gland, lung, lymph node and
skin) and seven cases of staphylococcal
botryomycosis (Percy & Barthold 2001).
These bacterial infections did not seriously
hinder individual scientific programmes
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because they occurred only sporadically in
individual strains. On the other hand, reder-
ivation programme has excluded the FELASA
listed agents in the new mouse colonies and
this change in health status has been
accompanied by the elimination or marked
reduction in three previously important
disease entities in conventional mice: lacta-
tion ileus in C3H/HeH mice, early weight
loss due to IBD in transgenic Huntington
mice and substantial weight loss in
ENU-treated BALB/cAnNCrl males for
which there was direct histological evidence
for intercurrent MHV infection. The precise
role for individual FELASA agents is unclear
as these clinical entities are likely to be
multifactorial diseases with possible
environmental component(s). The aetiology
of lactation ileus is unknown, but it has been
suggested that endogenous clostridial infec-
tions and/or metabolic exhaustion may be
the underlying causes. No specific bacterial
pathogens have been identified (Kunsty´rˇ
1986). In our C3H/HeH colonies, the sus-
ceptible conventional females were fed the
same RM3 diet as the unaffected SPF
females, so the dietary background was
equivalent. The only difference was that the
SPF females in the new facility were fed
irradiated diet. It is possible that rederivation
has eliminated certain key intestinal patho-
gen(s) responsible for lactation ileus and
perhaps also IBD. For instance, under SPF
conditions a number of immunodeficient
mouse models do not have IBD, but develop
IBD after experimental infection with
Helicobacter spp. (see Discussion in Fox
et al. 2000). It remains to be determined
whether mucosal immunity or gut physi-
ology is impaired in Huntington mice pre-
disposing them to bacterial IBD. The role of
MHV in weight loss in ENU-treated mice is
perhaps the clearest because ENU is a stem
cell mutagen that affects the haematopoietic
stem cells causing acute immune suppres-
sion and susceptibility to viral infection
(Justice et al. 2000).
Working in the MRC MGU, it was of
considerable scientific interest to see
whether some mutant mouse phenotypes
would be lost or altered by rederivation.
Among the MRC Harwell programmes,
none of the neurobehavioural, diabetes,
developmental or neuromuscular mutant
phenotypes have been lost. However, two
altered phenotypes have been recognized
after rederivation into SPF conditions.
In the imprinted gene mutant C3H101H-
GnasOedsml-mat/H, subsequently referred to
as Oed-Sml (Cattanach et al. 2000), almost
all conventional Oed-Sml on a (C3H/HeH 
101/H)F1 background mice died within a
few days of birth, with fewer than five
individuals out of the several hundred born
surviving to weaning. Maternal inheritance
of the Oed-Sml mutation was maintained
by crossing to Mus musculus castaneus. In
contrast, 21 out of 31 rederived SPF
Oed-Sml on a (C3H/HeH  101/H)F1 back-
ground generated so far have reached
weaning before they were euthanized.
Although the numbers of mice are currently
small, pre-weaning mortality in Oed-Sml
mice on a (C3H/HeH  101/H)F1 back-
ground appears markedly reduced. This
breeding programme offers the potential for
the better standardization of genetic back-
ground in future experiments (Peters J &
Cattanach B, personal communication).
Another example of an altered phenotype is
in the deaf mutant Junbo. The chronic sup-
purative OM phenotype was milder and
late-onset OM under SPF conditions
(Parkinson et al. 2006). This observation has
led to a new line of enquiry to investigate
the role of normal nasopharynx staphylo-
coccal and streptococcal flora in OM and an
experiment to rear Junbo mice in germfree
conditions is now underway. One additional
outcome is that new disease phenotypes can
come to prominence in SPF conditions. We
have recently described exocrine pancreas
hypoplasia causing clinical steatorrhoea and
runting in SPF C3HeB/FeJ and 101/H pups.
This was probably overlooked in the pre-
existing colonies because the clinical signs
would be similar to some of the endemic
gastrointestinal infections such as MHV
(Cheeseman et al. 2007).
In round terms, the cost of mouse colony
rederivation spread over 30 months was
£106K, which approximates to 2% of the
annual recurrent costs of the MLC, and in
terms of manpower approximately 9.25
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person-years of work from a total FESA and
MLC workforce of 91. Viewed in the context
of the £18M MRC investment in the facility,
the cost of rederivation was relatively modest
and from the outset it was considered inte-
gral to the design and the mission of the
MLC. Any cost–benefit analysis has also to
take into account the cost to animal welfare,
remedial action and the potential interrup-
tion to the scientific programmes if we were
to deal with a major disease outbreak.
In summary, to our knowledge, we have
completed one of the larger one-off mouse
rederivation programmes. We adopted the
FELASA recommendations for health moni-
toring mice to help standardize the SPF
microbiological quality of animals. Although
rederivation techniques are intrinsically safe,
we took the precaution of rederiving mice in
isolators in a separate quarantine facility.
This facilitated the containment and decon-
tamination of two MHV infection outbreaks
emphasizing that the overall success of a
rederivation programme depends on coupling
high standards of embryo sanitization with
effective screening for infectious agents
within isolators. It is also clear that the
improvement in microbiological status of the
mice translates into better health and welfare
standards. Reducing the prevalence of
specific clinical diseases in strains of mice
minimizes the number of mice bred to
complete experiments. In addition, the
refinement and standardization of microbio-
logical status simplifies experimental design
and paves the way for better science. The
benefits also extend to improving the effi-
ciency of archiving mouse stocks and
upgrading the general health status of the
mutant mice which are distributed to the
wider scientific community.
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Addendum
In the interval between writing this paper, and its
going to press, a further 29 rederivation isolation
cycles have been completed in quarantine without a
disease breakdown. The rolling programme of
sentinel screens in the MLC wards shows that the
colony remains free of FELASA agents.
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